Please enable JavaScript to continue using this application.

Compare $CRBP vs $HSTC | Chartloom

Compare

$CRBP vs $HSTC

Corbus Pharmaceuticals Holdings Inc · HST Global Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

HSTC

HST Global Inc

Compare $CRBP vs $HSTC

Comparing Corbus Pharmaceuticals Holdings Inc and HST Global Inc

CRBPCorbus Pharmaceuticals Holdings Inc

HSTCHST Global Inc

CRBPCorbus Pharmaceuticals Holdings Inc

Market cap

$100M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-31.6%

52W performance

-59.9%

FCF yield

-87.0%

HSTCHST Global Inc

Market cap

$99M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.3%

52W performance

438.5%

FCF yield

-0.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRBP

HSTC

Detailed metrics comparison

CRBP

Corbus Pharmaceuticals Holdings Inc

HSTC

HST Global Inc

Market Cap

CRBP$100M

HSTC$99M

Enterprise Value

CRBP$76M

HSTC$99M

Price

CRBP$5.38

HSTC$0.70

P/E Ratio

CRBPN/A

HSTCN/A

P/S Ratio

CRBP76.49x

HSTC6.52x

EV/Sales

CRBP61.41x

HSTC0.00x

EV/EBITDA

CRBP0.00x

HSTC227.13x

P/B Ratio

CRBP1.16x

HSTC17.75x

P/FCF Ratio

CRBPN/A

HSTCN/A

EV/FCF

CRBP-0.88x

HSTC-782.53x

PEG Ratio

CRBPN/A

HSTCN/A

Forward P/E (NTM)

CRBPN/A

HSTCN/A

Forward P/S (NTM)

CRBPN/A

HSTCN/A

Revenue (TTM)

CRBP$0

HSTC$0

Revenue Growth (YoY)

CRBPN/A

HSTCN/A

Forward Rev Growth

CRBP116.0%

HSTC0.0%

Gross Margin (TTM)

CRBP0.0%

HSTC0.0%

Operating Margin (TTM)

CRBP0.0%

HSTC0.0%

EBITDA Margin (TTM)

CRBP0.0%

HSTC0.0%

Net Margin (TTM)

CRBP0.0%

HSTC0.0%

FCF Margin (TTM)

CRBPN/A

HSTCN/A

Net Income (TTM)

CRBP$-102M

HSTC$-51K

FCF (TTM)

CRBP$-87M

HSTC$-127K

EPS (TTM)

CRBP-$5.25

HSTC$0.00

ROE (TTM)

CRBP-8705.0%

HSTC2453.5%

ROA (TTM)

CRBP-7422.0%

HSTC-349482.0%

ROIC (TTM)

CRBP-8705.0%

HSTC2453.5%

Cash

CRBP$23M

HSTC$29K

Debt

CRBP$0

HSTC$252K

Net Cash/Debt

CRBP$23M

HSTC$-224K

Current Ratio (TTM)

CRBP5.71x

HSTC0.08x

Quick Ratio (TTM)

CRBP5.62x

HSTC0.08x

Debt/Equity (TTM)

CRBP0.00x

HSTC0.05x

Debt/Assets (TTM)

CRBP0.0%

HSTC0.0%

Interest Coverage (TTM)

CRBPN/A

HSTCN/A

Net Debt/EBITDA (TTM)

CRBP0.00x

HSTC0.00x

Beta

CRBP2.74

HSTC-349.46

52W Performance

CRBP-59.9%

HSTC438.5%

YTD Performance

CRBP-31.6%

HSTC-29.3%

% from 52W High

CRBP-73.8%

HSTC-39.1%

% from 52W Low

CRBP4.9%

HSTC699900.0%

Asset Turnover (TTM)

CRBP0.01x

HSTC0.79x

FCF Yield (TTM)

CRBP-87.0%

HSTC-0.1%

Earnings Yield (TTM)

CRBP-102.2%

HSTC-0.1%

Dividend Yield (TTM)

CRBPN/A

HSTCN/A

Rule of 40

CRBP0.0

HSTC0.0

EV/GP/RG

CRBPN/A

HSTCN/A

Ticker research

View CRBP research View HSTC research

Metric	CRBP Corbus Pharmaceuticals Holdings Inc	HSTC HST Global Inc
Market & Valuation
Market Cap	$100M	$99M
Enterprise Value	$76M	$99M
Price	$5.38	$0.70
P/E Ratio	N/A	N/A
P/S Ratio	76.49x	6.52x
EV/Sales	61.41x	0.00x
EV/EBITDA	0.00x	227.13x
P/B Ratio	1.16x	17.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.88x	-782.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	116.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-102M	$-51K
FCF (TTM)	$-87M	$-127K
EPS (TTM)	-$5.25	$0.00
ROE (TTM)	-8705.0%	2453.5%
ROA (TTM)	-7422.0%	-349482.0%
ROIC (TTM)	-8705.0%	2453.5%
Financial Health
Cash	$23M	$29K
Debt	$0	$252K
Net Cash/Debt	$23M	$-224K
Current Ratio (TTM)	5.71x	0.08x
Quick Ratio (TTM)	5.62x	0.08x
Debt/Equity (TTM)	0.00x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.74	-349.46
52W Performance	-59.9%	438.5%
YTD Performance	-31.6%	-29.3%
% from 52W High	-73.8%	-39.1%
% from 52W Low	4.9%	699900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.79x
FCF Yield (TTM)	-87.0%	-0.1%
Earnings Yield (TTM)	-102.2%	-0.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBP research	View HSTC research

Valuation

P/S Ratio

HSTC

6.52x

CRBP

76.49x

EV/FCF

HSTC

-782.53x

CRBP

-0.88x

Growth & revenue

Forward Revenue Growth

CRBP

116.0%

HSTC

0.0%

Profitability & performance

Gross Margin

CRBP

0.0%

HSTC

0.0%

ROE

HSTC

2453.5%

CRBP

-8705.0%

FCF Yield %

HSTC

-0.1%

CRBP

-87.0%

52-Week Performance

HSTC

438.5%

CRBP

-59.9%

Detailed metrics comparison

CRBP

Corbus Pharmaceuticals Holdings Inc

HSTC

HST Global Inc

Market Cap

CRBP$100M

HSTC$99M

Enterprise Value

CRBP$76M

HSTC$99M

Price

CRBP$5.38

HSTC$0.70

P/E Ratio

CRBPN/A

HSTCN/A

P/S Ratio

CRBP76.49x

HSTC6.52x

EV/Sales

CRBP61.41x

HSTC0.00x

EV/EBITDA

CRBP0.00x

HSTC227.13x

P/B Ratio

CRBP1.16x

HSTC17.75x

P/FCF Ratio

CRBPN/A

HSTCN/A

EV/FCF

CRBP-0.88x

HSTC-782.53x

PEG Ratio

CRBPN/A

HSTCN/A

Forward P/E (NTM)

CRBPN/A

HSTCN/A

Forward P/S (NTM)

CRBPN/A

HSTCN/A

Revenue (TTM)

CRBP$0

HSTC$0

Revenue Growth (YoY)

CRBPN/A

HSTCN/A

Forward Rev Growth

CRBP116.0%

HSTC0.0%

Gross Margin (TTM)

CRBP0.0%

HSTC0.0%

Operating Margin (TTM)

CRBP0.0%

HSTC0.0%

EBITDA Margin (TTM)

CRBP0.0%

HSTC0.0%

Net Margin (TTM)

CRBP0.0%

HSTC0.0%

FCF Margin (TTM)

CRBPN/A

HSTCN/A

Net Income (TTM)

CRBP$-102M

HSTC$-51K

FCF (TTM)

CRBP$-87M

HSTC$-127K

EPS (TTM)

CRBP-$5.25

HSTC$0.00

ROE (TTM)

CRBP-8705.0%

HSTC2453.5%

ROA (TTM)

CRBP-7422.0%

HSTC-349482.0%

ROIC (TTM)

CRBP-8705.0%

HSTC2453.5%

Cash

CRBP$23M

HSTC$29K

Debt

CRBP$0

HSTC$252K

Net Cash/Debt

CRBP$23M

HSTC$-224K

Current Ratio (TTM)

CRBP5.71x

HSTC0.08x

Quick Ratio (TTM)

CRBP5.62x

HSTC0.08x

Debt/Equity (TTM)

CRBP0.00x

HSTC0.05x

Debt/Assets (TTM)

CRBP0.0%

HSTC0.0%

Interest Coverage (TTM)

CRBPN/A

HSTCN/A

Net Debt/EBITDA (TTM)

CRBP0.00x

HSTC0.00x

Beta

CRBP2.74

HSTC-349.46

52W Performance

CRBP-59.9%

HSTC438.5%

YTD Performance

CRBP-31.6%

HSTC-29.3%

% from 52W High

CRBP-73.8%

HSTC-39.1%

% from 52W Low

CRBP4.9%

HSTC699900.0%

Asset Turnover (TTM)

CRBP0.01x

HSTC0.79x

FCF Yield (TTM)

CRBP-87.0%

HSTC-0.1%

Earnings Yield (TTM)

CRBP-102.2%

HSTC-0.1%

Dividend Yield (TTM)

CRBPN/A

HSTCN/A

Rule of 40

CRBP0.0

HSTC0.0

EV/GP/RG

CRBPN/A

HSTCN/A

Ticker research

View CRBP research View HSTC research

Metric	CRBP Corbus Pharmaceuticals Holdings Inc	HSTC HST Global Inc
Market & Valuation
Market Cap	$100M	$99M
Enterprise Value	$76M	$99M
Price	$5.38	$0.70
P/E Ratio	N/A	N/A
P/S Ratio	76.49x	6.52x
EV/Sales	61.41x	0.00x
EV/EBITDA	0.00x	227.13x
P/B Ratio	1.16x	17.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.88x	-782.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	116.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-102M	$-51K
FCF (TTM)	$-87M	$-127K
EPS (TTM)	-$5.25	$0.00
ROE (TTM)	-8705.0%	2453.5%
ROA (TTM)	-7422.0%	-349482.0%
ROIC (TTM)	-8705.0%	2453.5%
Financial Health
Cash	$23M	$29K
Debt	$0	$252K
Net Cash/Debt	$23M	$-224K
Current Ratio (TTM)	5.71x	0.08x
Quick Ratio (TTM)	5.62x	0.08x
Debt/Equity (TTM)	0.00x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.74	-349.46
52W Performance	-59.9%	438.5%
YTD Performance	-31.6%	-29.3%
% from 52W High	-73.8%	-39.1%
% from 52W Low	4.9%	699900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.79x
FCF Yield (TTM)	-87.0%	-0.1%
Earnings Yield (TTM)	-102.2%	-0.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBP research	View HSTC research